Rudolf Stadler

28PUBLICATIONS
97CO-AUTHORS
Predictive and prognostic markersAllergyMedical mycologyGene and molecular therapyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Feb 27, 2026
COMBI-EU: Real-World Evidence on Adverse Event Management and Time on Therapy with Adjuvant Dabrafenib Plus Trametinib in Patients with BRAF V600-Mutant Melanoma.

Michael Weichenthal, Dirk Debus, Lisa Zimmer

|Jan 20, 2026
How I manage mycosis fungoides and Sézary syndrome: Current controversies and unmet needs.

Rudolf Stadler, Pietro Quaglino, Gabriele Roccuzzo

|Jan 10, 2026
Brentuximab Vedotin in Advanced-Stage Mycosis Fungoides/Sézary Syndrome with Low CD30 Expression: Real-World Data from the German Cutaneous Lymphoma Network.

Christoph Blazejak, Mathias Oymanns, René Stranzenbach

|Aug 23, 2025
Low-dose total skin electron beam therapy in erythrodermic mycosis fungoides and Sézary syndrome: Results From the Prospective S-MISR Study.

Khaled Elsayad, Christian Kandler, Jan Jakob Siats

|Jul 15, 2025
A new prognostic index (CLIPI) for advanced cutaneous lymphoma enables precise patient risk stratification.

Julia J Scarisbrick, Pietro Quaglino, Sean Whittaker

|Feb 13, 2025
T-Cell Receptor Rearrangements in Early Stages of Mycosis Fungoides May Be Associated with Pronounced Copy Number Variations: A Prognostic Factor?

Carsten Hain, Cassandra Cieslak, Jörn Kalinowski

Pageof 5

Frequent Collaborators

6 joint publications

Marion Wobser

6 joint publications

Emmanuella Guenova

5 joint publications

Julia Scarisbruck

5 joint publications

Ulrike Wehkamp